Andrew Salzman Insider Profile
4 Followers
Andrew Salzman, Chief Executive Officer, Ten Percent Owner at Claritas Pharmaceuticals, holds 5.40M shares in Claritas Pharmaceuticals (Ticker: CLAZF). Most recently, Andrew Salzman Sold 24,500 shares of Claritas Pharmaceuticals on Oct 12, 2021 for an estimated value of $8.82K.
Andrew Salzman's Trading History
| CLAZFClaritas Pharmaceuticals | Oct 12, 2021 | Chief Executive Officer, Ten Percent Owner | Informative Sell | 8.82K | ― | ||||||||||||||||||||||||||||||||||||
CLAZF Insider Shares: 5.40M (1523.66%)
| |||||||||||||||||||||||||||||||||||||||||
You May Also Like
Andrew Salzman insider profile FAQ
What is the percentage of profitable transactions made by Andrew Salzman?
The percentage of profitable transactions made by Andrew Salzman is 100%.
What is the average return per transaction made by Andrew Salzman?
The average return per transaction made by Andrew Salzman is 88.60%.
What stocks does Andrew Salzman hold?
Andrew Salzman holds: CLAZF stocks.
What was Andrew Salzman’s latest transaction?
Andrew Salzman’s latest transaction was an Informative Sell of $8.82K.
What was Andrew Salzman's most profitable transaction?
Andrew Salzman’s most profitable transaction was an Informative Sell of CLAZF stock on October 12, 2021. The return on the trade was 89.00%.
What is Andrew Salzman's role in Claritas Pharmaceuticals?
Andrew Salzman's role in Claritas Pharmaceuticals is Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
